Nick Dragojlovic

1.1k total citations
39 papers, 655 citations indexed

About

Nick Dragojlovic is a scholar working on Genetics, Economics and Econometrics and Sociology and Political Science. According to data from OpenAlex, Nick Dragojlovic has authored 39 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 12 papers in Economics and Econometrics and 9 papers in Sociology and Political Science. Recurrent topics in Nick Dragojlovic's work include Genomics and Rare Diseases (15 papers), BRCA gene mutations in cancer (10 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Nick Dragojlovic is often cited by papers focused on Genomics and Rare Diseases (15 papers), BRCA gene mutations in cancer (10 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Nick Dragojlovic collaborates with scholars based in Canada, Netherlands and Australia. Nick Dragojlovic's co-authors include Larry D. Lynd, Edna Einsiedel, Alison M. Elliott, Jan M. Friedman, Shelin Adam, Christèle du Souich, Patricia Birch, Anna Lehman, Clara van Karnebeek and Amy Nisselle and has published in prestigious journals such as Technological Forecasting and Social Change, Biomass and Bioenergy and Drug Discovery Today.

In The Last Decade

Nick Dragojlovic

39 papers receiving 638 citations

Peers

Nick Dragojlovic
Ine Van Hoyweghen Belgium
Susan Wallace United Kingdom
Catherine Heeney United Kingdom
Herbert Gottweis Austria
David E. Winickoff United States
Christi J. Guerrini United States
Stephen Rose United Kingdom
Stephen J. Miller United States
Alexander Hamilton Sweden
Yoshikuni Ono Japan
Ine Van Hoyweghen Belgium
Nick Dragojlovic
Citations per year, relative to Nick Dragojlovic Nick Dragojlovic (= 1×) peers Ine Van Hoyweghen

Countries citing papers authored by Nick Dragojlovic

Since Specialization
Citations

This map shows the geographic impact of Nick Dragojlovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Dragojlovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Dragojlovic more than expected).

Fields of papers citing papers by Nick Dragojlovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Dragojlovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Dragojlovic. The network helps show where Nick Dragojlovic may publish in the future.

Co-authorship network of co-authors of Nick Dragojlovic

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Dragojlovic. A scholar is included among the top collaborators of Nick Dragojlovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Dragojlovic. Nick Dragojlovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elliott, Alison M., Jehannine Austin, Bartha Maria Knoppers, et al.. (2025). The impact of genetic counselor involvement in genetic and genomic test order review: A scoping review. Genetics in Medicine. 27(3). 101354–101354. 2 indexed citations
2.
Regier, Dean A., Brandon Chan, Samantha Pollard, et al.. (2024). Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada. Genetics in Medicine. 26(4). 101069–101069. 9 indexed citations
3.
Dragojlovic, Nick, et al.. (2023). Defining Need Amid Exponential Change: Conceptual Challenges in Workforce Planning for Clinical Genetic Services. Clinical Therapeutics. 45(8). 695–701. 3 indexed citations
4.
Dragojlovic, Nick, et al.. (2023). Workforce Implications of Increased Referrals to Hereditary Cancer Services in Canada: A Scenario-Based Analysis. Current Oncology. 30(8). 7241–7251. 5 indexed citations
5.
Dragojlovic, Nick, et al.. (2023). Frameworks for Health Technology Assessment at an Early Stage of Product Development: A Review and Roadmap to Guide Applications. Value in Health. 26(8). 1258–1269. 6 indexed citations
6.
Dragojlovic, Nick, Jan M. Friedman, Horacio Osiovich, et al.. (2022). The effect of rapid exome sequencing on downstream health care utilization for infants with suspected genetic disorders in an intensive care unit. Genetics in Medicine. 24(8). 1675–1683. 4 indexed citations
7.
Dragojlovic, Nick, et al.. (2022). Where is genetic medicine headed? Exploring the perspectives of Canadian genetic professionals on future trends using the Delphi method. European Journal of Human Genetics. 30(5). 496–504. 13 indexed citations
8.
Morris, Emily, Bartha Maria Knoppers, Larry D. Lynd, et al.. (2022). The stepwise process of integrating a genetic counsellor into primary care. European Journal of Human Genetics. 30(7). 772–781. 24 indexed citations
9.
Pollard, Samantha, Deirdre Weymann, Jessica L. Dunne, et al.. (2021). Toward the diagnosis of rare childhood genetic diseases: what do parents value most?. European Journal of Human Genetics. 29(10). 1491–1501. 29 indexed citations
10.
Dragojlovic, Nick, et al.. (2021). Far and wide: Exploring provider utilization of remote service provision for genome‐wide sequencing in Canada. Molecular Genetics & Genomic Medicine. 9(10). e1784–e1784. 3 indexed citations
11.
Dragojlovic, Nick, et al.. (2021). Economic Evidence on Potentially Curative Gene Therapy Products: A Systematic Literature Review. PharmacoEconomics. 39(9). 995–1019. 7 indexed citations
12.
Dragojlovic, Nick, Ursula Ellis, Patricia Birch, et al.. (2020). The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genetics in Medicine. 22(9). 1437–1449. 83 indexed citations
13.
Dragojlovic, Nick, et al.. (2020). Evaluating New Zealanders’ Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common Conditions. PharmacoEconomics. 39(1). 109–119. 5 indexed citations
14.
Weymann, Deirdre, Nick Dragojlovic, Samantha Pollard, & Dean A. Regier. (2019). Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges. Journal of Community Genetics. 13(5). 467–476. 22 indexed citations
15.
Dragojlovic, Nick, et al.. (2018). Evaluating the use of parental reports to estimate health care resource utilization in children with suspected genetic disorders. Journal of Evaluation in Clinical Practice. 24(2). 416–422. 7 indexed citations
16.
Bansback, Nick, Nick Dragojlovic, Kathy H. Li, et al.. (2018). Evaluating Canadians’ Values for Drug Coverage Decision Making. Value in Health. 22(3). 362–369. 16 indexed citations
17.
Dragojlovic, Nick, Alison M. Elliott, Shelin Adam, et al.. (2018). The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study. Genetics in Medicine. 20(9). 1–9. 61 indexed citations
18.
Dragojlovic, Nick & Larry D. Lynd. (2016). What will the crowd fund? Preferences of prospective donors for drug development fundraising campaigns. Drug Discovery Today. 21(12). 1863–1868. 15 indexed citations
19.
Dragojlovic, Nick & Larry D. Lynd. (2014). Crowdfunding drug development: the state of play in oncology and rare diseases. Drug Discovery Today. 19(11). 1775–1780. 33 indexed citations
20.
Dragojlovic, Nick. (2013). Canadians' support for radical life extension resulting from advances in regenerative medicine. Journal of Aging Studies. 27(2). 151–158. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ine Van Hoyweghen Breakdown of academic impact, for papers by Susan Wallace Breakdown of academic impact, for papers by Catherine Heeney Breakdown of academic impact, for papers by Herbert Gottweis Breakdown of academic impact, for papers by David E. Winickoff Breakdown of academic impact, for papers by Christi J. Guerrini Breakdown of academic impact, for papers by Stephen Rose Breakdown of academic impact, for papers by Stephen J. Miller Breakdown of academic impact, for papers by Alexander Hamilton Breakdown of academic impact, for papers by Yoshikuni Ono
Rankless by CCL
2026